Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Introduction | p. iii |
Foreword | p. v |
Preface | p. ix |
Contributors | p. xi |
Breathing and Sleep States in the Fetus and at Birth | p. 1 |
Introduction | p. 1 |
Animal Studies | p. 1 |
Human Studies | p. 8 |
Transition to Postnatal Respiration | p. 10 |
Summary | p. 12 |
References | p. 12 |
Laryngeal Function and Neonatal Respiration | p. 19 |
Introduction | p. 19 |
Overview of Laryngeal Function | p. 20 |
Perinatal "Respiratory" Function of the Larynx | p. 20 |
The Larynx and Apneas in the Newborn | p. 23 |
Laryngeal Chemoreflexes | p. 29 |
Swallowing and Respiration in the Newborn | p. 32 |
Laryngeal Function and Nasal Ventilatory Support | p. 39 |
Conclusion | p. 41 |
References | p. 41 |
Postnatal Development of Carotid Chemoreceptor Function | p. 47 |
Overview | p. 47 |
The Carotid Chemoreceptors in Normal Breathing Control in Childhood | p. 48 |
Developmental Changes in O[subscript 2] Chemoreflexes | p. 56 |
Developmental Changes in Afferent Chemoreceptor Nerve Activity | p. 58 |
Mechanisms of Developmental Changes | p. 61 |
The Carotid Chemoreceptors and Abnormal Breathing Control in Children | p. 71 |
Summary | p. 72 |
References | p. 73 |
Maturation and Plasticity of Central Components in Cardiovascular and Respiratory Control | p. 83 |
Introduction | p. 83 |
Plasticity of Respiratory Control | p. 84 |
Central Chemosensitivity | p. 94 |
Autonomic Development: Interactions with Breathing and Sleep | p. 95 |
Developmental Trends in Cardiovascular and Respiratory Measures | p. 96 |
Neural Structures Involved in Autonomic and Respiratory Regulation: Cerebellum and Vestibular Regions | p. 97 |
Sleep State Effects | p. 98 |
VMS Activity | p. 99 |
Rostral Brain Influences | p. 100 |
Potential Implications to SIDS | p. 102 |
Summary | p. 103 |
References | p. 104 |
Maturation of Breathing During Sleep | p. 117 |
Introduction | p. 117 |
Normal Respiration During Sleep: An Overview | p. 118 |
Ventilation, Respiratory Patterns, and Apneas | p. 118 |
Gas Exchange | p. 122 |
Summary | p. 126 |
References | p. 126 |
Interaction Between Upper Airway Muscles and Structures During Sleep | p. 131 |
Introduction | p. 131 |
Pharyngeal Maintenance Mechanisms | p. 131 |
Methodology of Pharyngeal Airway Maintenance Mechanisms | p. 137 |
Developmental Changes in Pharyngeal Airway Patency | p. 141 |
Mechanical Influences on Pharyngeal Airway Patency | p. 147 |
References | p. 152 |
Craniofacial Development and the Airway During Sleep | p. 157 |
Introduction | p. 157 |
Principles of Craniofacial Growth | p. 162 |
Craniofacial Pattern and OSAS | p. 164 |
Abnormal Patterns of Craniofacial Growth | p. 167 |
Conclusion | p. 171 |
References | p. 172 |
Breathing and Sleep in Preterm Infants | p. 177 |
Introduction | p. 177 |
History | p. 178 |
Classification and Development of Sleep in Preterm Infants | p. 179 |
Sleep States and Arousal from Sleep | p. 179 |
The Effects of Sleep on the Functional and Mechanical Properties of the Respiratory System in Preterm Infants | p. 181 |
The Effects of Sleep on the Breathing Pattern | p. 185 |
The Effects of Sleep on Ventilation | p. 191 |
Clinical Conditions Affected by Sleep | p. 197 |
Conclusions | p. 200 |
References | p. 201 |
Apnea During Infancy | p. 211 |
Introduction | p. 211 |
Normative Data in Healthy Term Infants | p. 212 |
Idiopathic ALTE | p. 217 |
Summary | p. 223 |
References | p. 224 |
Apparent Life-Threatening Events: Pathogenesis and Management | p. 229 |
Introduction | p. 229 |
Relationship to Sudden Infant Death | p. 230 |
Definition | p. 230 |
The Evidence Base | p. 231 |
Epidemiology | p. 232 |
Causes | p. 232 |
History and Examination | p. 234 |
Initial Management and Investigations | p. 235 |
Physiology | p. 237 |
Multichannel Recordings | p. 238 |
Medical Causes | p. 238 |
Psychological Assessment | p. 243 |
Discharge Planning and Home Monitoring | p. 243 |
Specific Management for Recurrent ALTE | p. 245 |
Outcome | p. 246 |
References | p. 246 |
Pathophysiology of Sudden Infant Death Syndrome | p. 255 |
Pathophysiology of Sudden Infant Death Syndrome | p. 255 |
Failure to Autoresuscitate from Severe Hypoxia | p. 256 |
Abnormal Chemoreceptor Function Hypothesis | p. 256 |
Obstructive Sleep Apnea and Apnea of Prematurity as a Cause of SIDS and the Potential Role of Viral Infection | p. 257 |
OSA, A Cause of SIDS | p. 259 |
Cardiac Hypothesis for SIDS | p. 260 |
Accidental Suffocation and Thermal Stress Theories | p. 261 |
Metabolic Deficiencies Presenting as SIDS | p. 263 |
Brain Stem Pathology and SIDS | p. 263 |
References | p. 264 |
Sudden Infant Deaths: Risk Factors, Contributory Factors, and Causal Factors | p. 269 |
Introduction | p. 269 |
Investigation and Classification of Unexpected Infant Deaths | p. 269 |
The Epidemiology of Unexpected Infant Deaths: Modifiable and Nonmodifiable Risk Factors | p. 272 |
Infant Physiology and the Pathophysiology of Unexpected Death | p. 280 |
The "Triple Risk" Hypotheses and Prospects for Prevention of SUDI | p. 282 |
Current Recommendations | p. 283 |
References | p. 283 |
Sudden Infant Death Syndrome: Genetic Studies in Cardiorespiratory and Autonomic Regulation | p. 293 |
Introduction | p. 293 |
Cardiac Channelopathy Genes in SIDS | p. 293 |
Serotonergic System Genes in SIDS | p. 295 |
Autonomic Nervous System Genes in SIDS | p. 298 |
Nicotine Metabolizing Genes in SIDS | p. 303 |
Summary and Clinical Significance | p. 304 |
Future Directions | p. 307 |
References | p. 308 |
Effects of Intermittent Hypoxia on the Developing Organism | p. 315 |
Background and Introduction | p. 315 |
Clinical Context (Diseases Producing Intermittent Hypoxia) | p. 317 |
Risk Factors for Sudden Infant Death Syndrome | p. 318 |
Responses to Hypoxia | p. 319 |
Responses to Reoxygenation | p. 321 |
Effects of Intermittent Hypoxia and Reoxygenation | p. 324 |
Specific Effects of Intermittent Hypoxia and Reoxygenation Cycle During Early Development | p. 325 |
Plasticity | p. 329 |
Models of Intermittent Hypoxia | p. 331 |
Implications of Current Research and Future Directions | p. 331 |
References | p. 332 |
Influence of Prenatal Nicotine Exposure on Development of Neurotransmission in Central Respiratory Neurons | p. 341 |
Introduction | p. 341 |
Prenatal Nicotine Exposure and Cholinergic Neurotransmission | p. 342 |
Prenatal Nicotine Exposure and Fast Inhibitory Neurotransmission | p. 345 |
Prenatal Nicotine Exposure and Fast Excitatory Neurotransmission | p. 349 |
Prenatal Nicotine Exposure and Modulatory Neurotransmission: Serotonin | p. 351 |
Prenatal Nicotine Exposure and Modulatory Neurotransmission: Catecholamines | p. 354 |
Translational Physiology | p. 354 |
References | p. 355 |
Central Hypoventilation Syndromes | p. 363 |
Introduction | p. 363 |
Congenital Central Hypoventilation Syndrome | p. 363 |
Myelomeningocele with Arnold-Chiari Malformation | p. 368 |
Prader-Willi Syndrome | p. 370 |
Achondroplasia and Other Skeletal Dysplasias | p. 372 |
Leigh's Disease | p. 373 |
Joubert Syndrome | p. 374 |
Acquired Central Hypoventilation Syndromes | p. 374 |
Management of Respiratory Failure in Children with Respiratory Control Disorders | p. 375 |
Summary | p. 378 |
References | p. 378 |
Genetic Basis for Congenital Central Hypoventilation Syndrome | p. 383 |
Introduction | p. 383 |
Tentative Mutant Newborn Mouse Models of CCHS | p. 384 |
PHOX2B Gene Mutations in CCHS and LO-CHS Patients | p. 386 |
Mode of Inheritance | p. 387 |
Phenotype-Genotype Relationships | p. 388 |
Molecular Consequences of PHOX2B Gene Mutations | p. 389 |
Does the PHOX2B Gene Defect Fully Account for the Pathogenesis of CCHS? | p. 390 |
Conclusion and Perspectives | p. 391 |
References | p. 392 |
Epidemiology of Pediatric Obstructive Sleep Apnea | p. 397 |
Introduction | p. 397 |
Prevalence | p. 397 |
Distribution of OSAS Among Population Subgroups | p. 404 |
OSAS Risk Factors | p. 404 |
Natural History of OSAS | p. 410 |
Health Outcomes Associated with OSAS | p. 411 |
Research Needs | p. 412 |
References | p. 412 |
Pathophysiology of Childhood OSAS: Structural Factors | p. 419 |
Introduction | p. 419 |
The Role of Anatomic Factors in the Pathophysiology of OSAS | p. 421 |
Summary | p. 433 |
References | p. 434 |
Pathophysiology of Childhood OSAS: Neuromotor Factors | p. 441 |
Introduction | p. 441 |
Factors Affecting Neuromotor Function During Sleep | p. 442 |
Natural Course of Childhood OSAS | p. 452 |
References | p. 453 |
Cognitive and Behavioral Consequences of Childhood OSAS | p. 461 |
Introduction | p. 461 |
Behavioral Regulation in Children with OSAS | p. 461 |
Evidence for a Relationship Between OSAS and ADHD | p. 465 |
Cognitive Deficits in Children with OSAS | p. 466 |
Moving Beyond Associations: Does OSAS Directly Cause or Contribute to Neurobehavioral Morbidity? | p. 469 |
Summary and Future Directions | p. 477 |
References | p. 479 |
Inflammatory Association with Childhood Obstructive Sleep Apnea Syndrome | p. 489 |
Introduction | p. 489 |
Local Inflammation | p. 490 |
Systemic Inflammation | p. 494 |
Intermittent Hypoxia and Inflammation | p. 494 |
Summary | p. 501 |
References | p. 501 |
Metabolic Aspects of Sleep Apnea in Children | p. 507 |
Introduction | p. 507 |
OSAS | p. 508 |
Obesity as a Risk Factor for OSAS | p. 509 |
The Metabolic Consequences of OSAS | p. 509 |
Sleep Disruption and Glucose Homeostasis | p. 512 |
IH and Metabolic Abnormalities | p. 513 |
IGF-1-A Possible Link Between OSAS and Impaired Glucose Metabolism | p. 514 |
Inflammation | p. 514 |
Adipokines | p. 516 |
Summary | p. 518 |
References | p. 518 |
Cardiovascular Complications of Childhood OSAS | p. 529 |
Overview | p. 529 |
From Intermittent Upper Airway Obstruction to Cardiovascular Complications: Proposed Chain of Events | p. 530 |
Cardiovascular Complications of OSAS | p. 535 |
Conclusions and Unanswered Questions for Future Research | p. 543 |
References | p. 544 |
Acoustic Reflectance | p. 553 |
Introduction | p. 553 |
Basic Principles of the Technique | p. 553 |
Applications | p. 557 |
Summary | p. 560 |
References | p. 561 |
Pediatric Obstructive Sleep Apnea Syndrome: 30 Years of Progress | p. 565 |
Introduction | p. 565 |
Diagnosis | p. 568 |
Pathogenesis | p. 570 |
Sequelae: Failure to Thrive | p. 571 |
Sequelae: The Heart and Cardiovascular System | p. 572 |
Sequelae: Neurobehavioral Consequences of Sleep Apnea | p. 573 |
Obesity | p. 575 |
Surgical Treatment | p. 576 |
Medical Treatments | p. 576 |
References | p. 578 |
Index | p. 587 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.